Martina Drawdy
Pediatric Endocrinology · Pensacola, FLNPI 1801054275
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,787 of the $3,430 with a category attached, or 81.3%. 27 manufacturers reported payments, led by Medtronic at 37.5% of the total. 2025 is the largest year on record at $1,762, more than ten times the $71 reported in 2019.
Across 114 payments — averaging $30.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Novo Nordisk$226
- Dexcom, Inc.$172
- Tandem Diabetes Care, Inc.$163
- Abbott$160
- BETA Bionics, Inc.$141
- plus $1K from 21 others
What the payments were for
- Travel & lodging$53015%
- Food & beverage$2,78781%
- Education$1133%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 22 | $1,285 |
| Novo Nordisk | 11 | $226 |
| Dexcom, Inc. | 7 | $172 |
| Tandem Diabetes Care, Inc. | 8 | $163 |
| Abbott | 8 | $160 |
| BETA Bionics, Inc. | 2 | $141 |
| Ascendis Pharma Endocrinology Inc | 5 | $128 |
| Insulet Corporation | 6 | $110 |
| Xeris Pharmaceuticals, Inc. | 5 | $106 |
| Eton Pharmaceuticals, Inc. | 3 | $83 |
| Biomarin Pharmaceutical Inc. | 3 | $81 |
| Rhythm Pharmaceuticals, Inc. | 3 | $75 |
| Arbor Pharmaceuticals, Inc. | 4 | $74 |
| AstraZeneca | 3 | $71 |
| AbbVie | 4 | $71 |
| Ultragenyx Pharmaceutical Inc. | 2 | $69 |
| Amneal Pharmaceuticals LLC | 3 | $54 |
| Neurocrine Biosciences, Inc. | 2 | $54 |
| Sequel Med Tech, LLC | 2 | $53 |
| Corcept Therapeutics | 1 | $49 |
| Azurity Pharmaceuticals, Inc. | 2 | $41 |
| Tolmar, Inc. | 2 | $40 |
| Tolmar Pharmaceuticals, Inc. | 2 | $38 |
| Amgen | 1 | $25 |
| Bayer | 1 | $22 |
| Recordati_rare_diseases_inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,430 in reported general payments places this provider in the 65th percentile of 102 pediatric endocrinology providers in Florida.
Other pediatric endocrinology in Pensacola
- Jean Claude DesmanglesPensacola$2K
- Kelly SeilerPensacola$1K
- Joshua YangOrlando$846K
- Henry RodriguezTampa$211K
- Dorothy ShulmanTampa$104K
- Michael HallerGainesville$102K
- Alejandro DiazMiami$101K
- Samuel FreedmanPembroke Pines$71K
- Jennifer MillerGainesville$57K
- Miladys Palau CollazoPort St Lucie$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.